IMD-1112

N/A

Report date: 2025/04/28 17:05:05

Base Information

Drug NameIMD-1112
Drug Alias NameIMD-1112
ClassificationBiologics
Mechanisms of ActionT cell surface glycoprotein CD3 inhibitorsAnti-CLDN18
TargetsT cell surface glycoprotein CD3Claudin-18 splice variant 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Affinity Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Affinity Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A